Insights into pediatric rhabdomyosarcoma research: challenges and goals

Overall survival rates for pediatric patients with high-risk or relapsed rhabdomyosarcoma (RMS) have not improved significantly since the 1980s. Recent studies have identified a number of targetable vulnerabilities in RMS, but these discoveries have infrequently translated into clinical trials. We p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pediatr Blood Cancer
Autors principals: Yohe, Marielle E., Heske, Christine M., Stewart, Elizabeth, Adamson, Peter C., Ahmed, Nabil, Antonescu, Cristina R., Chen, Eleanor, Collins, Natalie, Ehrlich, Alan, Galindo, Rene L., Gryder, Berkley E., Hahn, Heidi, Hammond, Sharon, Hatley, Mark E., Hawkins, Douglas S., Hayes, Madeline N., Hayes-Jordan, Andrea, Helman, Lee J., Hettmer, Simone, Ignatius, Myron S., Keller, Charles, Khan, Javed, Kirsch, David G., Linardic, Corinne M., Lupo, Philip J., Rota, Rossella, Shern, Jack F., Shipley, Janet, Sindiri, Sivasish, Tapscott, Stephen J., Vakoc, Christopher R., Wexler, Leonard H., Langenau, David M.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6707829/
https://ncbi.nlm.nih.gov/pubmed/31222885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.27869
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars